Possible Case: UPDATE 1: Caraco Digoxin Recall

Possible Case: Caraco Brand 0.25 mg Digoxin Tablets Recalled

due to Size Variability

Settlement: J&J

Fined $4.5 Million for Duragesic and Risperdal Promotion

Information So You Can Make a Product Liability Claim

By Rudi ONeil -
It is taken as read that a product that gets purchased these days is going to be a safe product, based on the assumption that the product would have been subjected to a number of checks prior to being made available to a member of the public. Most of the time a [...]

Possible Case: Tarceva (erlotinib)

New Safety WarningS Added

Possible Case: Testosterone Gel

Safety Concerns Prompt FDA Label Changes

Possible Case: Heart Attack Test Kits

Recalled Nationwide

Possible Case: Oral Sodium Phosphate

or OSP has allegedly been recalled for acute kidney injury and kidney failure.

Settlement: $89 Million Settlement Proposed

in Bextra, Celebrex Marketing Class Action

Possible Case: FDA

Mandates Additional Labeling for Over-the-Counter Pain Relievers

Next Page »